Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Crescent Biopharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Geron Corporation May 20, 202698.5%
-
Crescent Biopharma Inc. June 5, 202583.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +35,400 | $0.86 | $30,444 |
| Dec 29, 2023 | Crescent Biopharma Inc. | Grant or award | +5,191 | $2.36 | $12,251 |
| Sep 30, 2023 | Crescent Biopharma Inc. | Grant or award | +8,167 | $1.50 | $12,251 |
Questions about Patricia S. Andrews
What boards is Patricia S. Andrews on?
Patricia S. Andrews sits on the boards of Crescent Biopharma Inc., Geron Corporation and Oncolytics Biotech Inc.
How long has Patricia S. Andrews served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.